Portfolio company
Immunitrack
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides epitope screening platforms and reagents to pharmaceutical and biotechnology organisations to predict and monitor immune responses during drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ImmuneSpec
This company provides immunopeptidomics analysis services to biotechnology and pharmaceutical firms to support vaccine development, immunotherapy research and biotherapeutic immunogenicity risk assessment.
Enpicom
This company develops bioinformatics software for immune repertoire sequencing data analysis to assist biotechnology and pharmaceutical firms in antibody discovery and development.
AAX Biotech
This company develops antibody engineering technologies for epitope mapping and fragment stabilisation to support pharmaceutical and biotechnology firms in drug discovery.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Immuneed
This company provides ex vivo whole blood analysis services to pharmaceutical and biotechnology companies for preclinical drug safety and function assessment.
48Hour Discovery
This company develops a peptide discovery platform and screening services for pharmaceutical and biotechnology organisations to accelerate drug development.
EpiVax Therapeutics
The company develops precision cancer immunotherapies using predictive algorithms to identify neo-epitopes for pharmaceutical and biotechnology clients.
Alithea Biotechnology GmbH
This company develops immunopeptidomics software and laboratory services for pharmaceutical, biotechnology and academic organisations developing cancer immunotherapies and vaccines.
